I am looking at Car-T solutions for Myeloma. The U.S. Bluebird version uses a single target while the Chinese Legend BCMA version uses a bi-spec or dual target . The Legend showed superior results but there is noise (obfuscation?) about their great results.
US treatment cost is 400,000 while the Chinese is 100,000 . Will keep an eye for a year or two to see if results stick and may need to dip into Super and do a medical holiday.
Currently on trial drug called Selinexor ( BOSTON) which was offered for my disease and treatment profile .. ( not high risk ) .
